Skip to main content
. 2024 Jul 3;6(10):1162–1169. doi: 10.1016/j.cjco.2024.06.010

Table 1.

Baseline characteristics

Characteristic Rural (n = 613) Urban (n = 520)
Age, y 72.1 (9.6) 72.6 (10.4)
Male sex 384 (62.6) 317 (61)
Systolic blood pressure, mm Hg, mean (SD) 129.72 (16.32) 127.13 (16.56)
Diastolic blood pressure, mm Hg, mean (SD) 74.06 (9.5) 73.77 (9.7)
Type of atrial fibrillation
 First episode 39 (6.4) 28 (5.4)
 Not documented 241 (39.3) 267 (51.4)
 Paroxysmal 170 (27.7) 134 (25.8)
 Persistent / chronic 163 (26.6) 91 (17.5)
CHADS2 score, mean (SD) 2.1 (1.36) 2.16 (1.34)
Previous stroke, systemic embolism, or transient ischemic attack 104 (17) 105 (20.2)
Congestive heart failure 146 (23.8) 145 (27.9)
Hypertension 490 (79.9) 401 (77.1)
Diabetes mellitus 189 (30.8) 138 (26.5)
Previous myocardial infarction 82 (13.4) 75 (14.4)
Vascular disease 206 (33.6) 192 (36.9)
Congenital heart disease 13 (2.1) 15 (2.9)
Obstructive sleep apnea 136 (22.2) 86 (16.5)
Tobacco use
 Current 38 (6.2) 27 (5.2)
 Former 266 (43.4) 187 (36)
Alcohol abuse 44 (7.2) 42 (8.1)
Pulmonary disease 233 (38) 151 (29)
CABG or PCI—combined group 83 (13.5) 78 (15)
Prior ablation (AF or atrial flutter) 39 (6.4) 37 (7.1)
Pacemaker / ICD 82 (13.4) 66 (12.7)
Any bleeding 200 (32.6) 154 (29.6)
Rate-control medications 431 (70.3) 340 (65.4)
Antiarrhythmic medications 59 (9.6) 40 (7.7)

Values are n (%), unless otherwise indicated.

AF, atrial fibrillation; CABG, coronary artery bypass grafting; CHADS2, score denoted by C = congestive heart failure (1), H = hypertension (1), A = age ≥ 75 years (1), D = diabetes (1), S = prior stroke or transient ischemic attack (2); ICD, implantable cardioverter defibrillator; PCI, percutaneous coronary intervention; SD, standard deviation.

P < 0.05 between the 2 groups.